Stratec Biomedical AG STRATEC BIO.../  DE000STRA555  /

LSE International Off-book
15.11.2024  17:00:12 Zm. +0,60 Wolumen Bid- Ask- Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
29,50EUR +2,08% 58
Obrót: 1 726,15
-Wolumen Bid: - -Wolumen Ask: - 353,74 mlnEUR 1,89% 27,20

Opis działalności

STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance. The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies. Shares in the company are traded in the Prime Standard segment of the Frankfurt Stock Exchange.
 

Zarząd & Rada nadzorcza

CEO
Marcus Wolfinger
Zarząd
Dr. Claus Vielsack, Dr. Robert Siegle, Dr. Georg Bauer
Rada nadzorcza
Prof. Dr. Georg Heni, Dr. Frank Hiller, Dr. Rolf Vornhagen, Dr. Patricia Geller
 

Dane firmy

Nazwa: STRATEC SE
Adres: Gewerbestraße 37,D-75217 Birkenfeld
Telefon: +49-7082-7916-0
Fax: +49-7082-7916-999
E-mail: info@stratec.com
Internet: www.stratec.com
Przemysł: Służba zdrowia
Sektor: Produkty Medyczne
Podsektor: Zaawansowane Urządzenia Medyczne
Koniec roku finansowego: 31.12
Free float: 35,57%
Data IPO: 25.08.1998

Relacje inwestorskie

Nazwa: Jan Keppeler
Telefon: +49-7082-7916-991
Fax: +49-7082-7916-9190
E-mail: ir@stratec.com

Główni akcjonariusze

Inne
 
86,96%
Invesco Ltd.
 
5,01%
Brown Capital Management, LLC
 
5,01%
Juno Investment Partners B.V
 
3,02%